Policy incentives are driving the vigorous development of innovative research and development in traditional Chinese medicine.
Release time:
2025-03-01
The country has introduced a series of policy measures to encourage innovation and R&D in traditional Chinese medicine, injecting strong momentum into the development of the TCM industry.
The country has introduced a series of policy measures to encourage innovation and R&D in traditional Chinese medicine (TCM), injecting strong momentum into the development of the TCM industry. These policies cover multiple aspects, including increasing investment in scientific research funding, streamlining approval procedures, and promoting collaboration among industry, academia, and research institutions. With the support of these policies, numerous TCM enterprises have stepped up their R&D investments and are collaborating with research institutes to develop new TCM drugs. Recently, several innovative TCM drugs with independent intellectual property rights have been approved for clinical trials. These new drugs have demonstrated unique advantages in the treatment of chronic and complex diseases. The vigorous development of TCM innovation and R&D not only helps preserve and promote TCM culture but also will provide the global pharmaceutical market with more safe and effective treatment options.
Address: 6th Floor, Building C6, Jiangsu Life Science and Technology Innovation Park, Qixia District, Nanjing City
Official account